The Journal of allergy and clinical immunology | 2019
Endolysin treatment against Staphylococcus aureus in adults with atopic dermatitis: a randomized controlled trial.
Abstract
Endolysin treatment against Staphylococcus aureus in this randomized vehicle-controlled trial was well tolerated, but had no topical corticosteroid sparing effect in patients with atopic dermatitis. The effective run-in with corticosteroids may have influenced the results.